Clinical Trial Update: TC-5214 as add-on the Treatment of Major Depressive Disorder [Phase 2]

View source ↗

Summary

Phase 2 trial of TC-5214 as add-on therapy for major depressive disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• TC-5214 (TC-5214)

Snippet

Sponsor: Targacept Inc. | Conditions: Major Depressive Disorder, Depression | Phase 2 | Status: COMPLETED